|
|
![]() | ![]() | ![]() | ![]() |
These excerpts taken from the ACCL 10-K filed May 26, 2009. Sales and Marketing We market our products and services worldwide. During fiscal year 2009, we generated 48%, 28% and 24% of our revenues from the United States, Europe and the Asia/Pacific region, respectively. Please refer to Note 2 to
6
Table of Contentsour consolidated financial statements included elsewhere in this Report for a breakdown of revenues and long-lived assets by geographic region. Our continuing reliance on sales in international markets exposes us to risks attendant to foreign sales, as described more fully in Item 1A of this Report. We sell our products and services through our direct sales force, telesales and, in some markets, arrangements with distributors. Our direct sales representatives focus on a defined list of customers or cover an assigned geographic territory. These direct sales representatives typically work closely with our pre-sales scientists in order to demonstrate our products and their applicability to various research and development efforts. Our telesales effort is directed at smaller sized commercial accounts and academic institutions. Our distributor relationships primarily exist in the Asia/Pacific region, specifically in Japan, China and Korea, and complement our direct sales force in those markets. In support of our sales activities, we participate in industry trade shows, publish our own newsletters, place advertisements in other industry publications, publish articles in industrial and scientific publications, conduct direct mail campaigns, sponsor industry conferences and seminars, and maintain a website that contains information about us and our product and service offerings. Our products, together with the associated product literature, are generally delivered to our customers at the time of placing and processing their order. Our electronic software distribution program allows our customers to download our products over the World Wide Web. Our customers buying habits have historically resulted in a higher concentration of sales in the third quarter of our fiscal year, due to traditionally higher purchasing activity in the month of December in many commercial organizations. Sales and Marketing FACE="Times New Roman" SIZE="2">We market our products and services worldwide. During fiscal year 2009, we generated 48%, 28% and 24% of our revenues from the United States, Europe and the Asia/Pacific region, respectively. Please refer to Note 2 to
6 Table of Contents
FACE="Times New Roman" SIZE="2">We sell our products and services through our direct sales force, telesales and, in some markets, arrangements with distributors. Our direct sales representatives focus on a defined list of customers or cover an In support of our sales activities, we participate in industry trade shows, publish our own newsletters, place advertisements in other Our products, together with the associated product literature, are generally delivered to our customers at the time of placing SIZE="2">Our customers buying habits have historically resulted in a higher concentration of sales in the third quarter of our fiscal year, due to traditionally higher purchasing activity in the month of December in many commercial These excerpts taken from the ACCL 10-K filed Jun 5, 2008. Sales and Marketing We market our products and services worldwide. During fiscal year 2008, we generated 49%, 29% and 22% of our revenues from the United States, Europe and the Asia/Pacific region, respectively. Please refer to Note 2 to our consolidated financial statements included elsewhere in this Report for a breakdown of revenues and long-lived assets by geographic region. Our continuing reliance on sales in international markets exposes us to risks attendant to foreign sales, as described more fully in Item 1A of this Report.
6
Table of ContentsWe sell our products and services through our direct sales force, telesales and, in some markets, arrangements with distributors. Our direct sales representatives focus on a defined list of customers or cover an assigned geographic territory. These direct sales representatives typically work closely with our pre-sales scientists in order to demonstrate our products and their applicability to various research and development efforts. Our telesales effort is directed at smaller sized commercial accounts and academic institutions. Our distributor relationships primarily exist in the Asia/Pacific region, specifically in Japan, China and Korea, and complement our direct sales force in those markets. In support of our sales activities, we participate in industry trade shows, publish our own newsletters, place advertisements in other industry publications, publish articles in industrial and scientific publications, conduct direct mail campaigns, sponsor industry conferences and seminars, and maintain a website that contains information about us and our product and service offerings. Our products, together with the associated product literature, are generally delivered to our customers at the time of placing and processing their order. Our electronic software distribution program allows our customers to download our products over the World Wide Web. Our customers buying habits have historically resulted in a higher concentration of sales in the third quarter of our fiscal year, due to traditionally higher purchasing activity in the month of December in many commercial organizations. Sales and Marketing FACE="Times New Roman" SIZE="2">We market our products and services worldwide. During fiscal year 2008, we generated 49%, 29% and 22% of our revenues from the United States, Europe and the Asia/Pacific region, respectively. Please refer to Note 2 to
6 Table of ContentsWe sell our products and services through our direct sales force, telesales and, in some markets, In support of our Our products, Our customers buying habits have historically resulted in a higher concentration of sales in the third quarter of our Product Development Development of our software is focused on expanding product lines, designing enhancements to our core technology and integrating existing totaling $17.8 million, $18.9 million, and $21.7 million, respectively. We have also licensed products or otherwise have acquired products, or portions of our products, from the open source community, as well as corporate, governmental and academic institutions. These arrangements sometimes involve joint development efforts and frequently require the payment of royalties by us. The development and royalty obligations, scope of distribution rights, duration and other terms of these arrangements vary depending on the product, the market, resource requirements, the other parties with which we contract and other factors. We intend to continue to license or otherwise acquire technology or products from third parties. STYLE="margin-top:18px;margin-bottom:0px">Competitors We believe our scientific operating FACE="Times New Roman" SIZE="2">The markets for our informatics software products and our computer aided design modeling and simulation products for the pharmaceutical and biotechnology industries are mature and intensely competitive, subject to
7 Table of Contents
The market for our This excerpt taken from the ACCL 10-K filed Jun 4, 2007. Sales and Marketing We market our products and services worldwide. Historically, we have generated approximately 55%, 25% and 20% of our revenues from the United States, Europe and the Asia/Pacific region, respectively. Please refer to Note 2 to our consolidated financial statements included elsewhere in this Report for a breakdown of revenues and long-lived assets by geographic region. Our continuing reliance on sales in international markets exposes us to risks attendant to foreign sales, as described more fully in Item 1A of this Report. We sell our products and services through our direct sales force, telesales and, in some markets, arrangements with distributors. Our direct sales representatives focus on a defined list of customers or cover an assigned geographic territory. These direct sales representatives typically work closely with our pre-sales scientists in order to demonstrate our products and their applicability to various research and development efforts. Our telesales effort is directed at smaller sized commercial accounts and academic institutions. Our distributor relationships primarily exist in the Asia/Pacific region, specifically in Japan, China and Korea, and complement our direct sales force in those markets. Historically, we have conducted a small percentage of our business via our webstore, and we are currently enhancing our web-based sales channel. In support of our sales activities, we participate in industry trade shows, publish our own newsletters, place advertisements in other industry publications, publish articles in industrial and scientific publications, conduct direct mail campaigns, sponsor industry conferences and seminars, and maintain a website that contains information about us and our product and service offerings. Our products, together with the associated product literature, are generally shipped to our customers at the time of placing and processing their order. We recently initiated an electronic software distribution (ESD) program, which allows our customers to download our products over the World Wide Web. Our customers buying habits have historically resulted in a higher concentration of sales in the third quarter of our fiscal year, due to traditionally higher purchasing activity in the month of December in many commercial organizations. 6 This excerpt taken from the ACCL 10-K filed May 24, 2006. We market our products and services worldwide. Historically, we have generated approximately 55%, 25% and 20% of our revenues from the United States, Europe and Asia-Pacific, respectively. Please refer to Note 3 to our restated consolidated financial statements included elsewhere in this Report for a breakdown of revenues and long-lived assets by geographic region. Our continuing reliance on sales in international markets exposes us to risks attendant to foreign sales, as described more fully in Item 1A of this Report. 6 We sell our products and services through our direct sales force, telesales and, in some markets, arrangements with distributors. Our direct sales representatives focus on a defined list of customers or cover an assigned geographic territory. These direct sales representatives typically work closely with our pre-sales scientists in order to demonstrate our products and their applicability to various research and development efforts. Our telesales effort is directed at smaller sized commercial accounts and academic institutions. Our distributor relationships are primarily focused in the Asian market, primarily in Japan, China and Korea, and complement our direct sales force in those markets. Historically, we have conducted a small percentage of our business via our webstore, and we are currently enhancing our web-based sales channel. In support of our sales activities, we participate in industry trade shows, publish our own newsletters, place advertisements in other industry publications, publish articles in industrial and scientific publications, conduct direct mail campaigns, sponsor industry conferences and seminars, and maintain a website that contains information about us and our product and service offerings. Our products, generally a CD-ROM containing the purchased software, together with the associated product literature, are generally shipped to our customers at the time of placing and processing their order. We recently initiated an electronic software distribution (ESD) pilot program, which, if implemented, will allow our customers to download our products over the World Wide Web. Our customers buying habits have historically resulted in a higher concentration of sales in the third quarter of our fiscal year, due to traditionally higher purchasing activity in the month of December in many commercial organizations. This excerpt taken from the ACCL 10-Q filed Aug 5, 2005. Sales and marketing expenses were 9% higher at $8.5 million for the three months
ended June 30, 2005 compared to $7.8 million for the three months
ended June 30, 2004. The increase in expenses was due to a $1.0 million
increase in sales and marketing costs as a result of the SciTegic acquisition
plus $0.6 for sales meeting and travel costs, partially offset by a $0.9
million reduction in sales and marketing costs as a result of the reduction in force
in March 2005.
This excerpt taken from the ACCL 10-K filed Jun 13, 2005. SALES AND MARKETING We market our products and services worldwide. Historically, the Company has generated approximately 50%, 30% and 20% of its revenues from the United States, EMEA (defined as Europe and Middle East and Africa) and Asia Pacific, respectively. In these regions we have direct sales forces, consisting of field sales, certain distributor arrangements, and telesales representatives. Certain of our telesales representatives focus exclusively on sales to academic researchers. The direct sales representatives and other telesales representatives work in teams selling to commercial and governmental accounts in assigned geographic territories. Our direct sales representatives typically focus on larger accounts and transactions and work closely with our pre-sales support scientists in order to demonstrate our products and their applicability to various research and development efforts. Our other distributor relationships are focused in the Asia market, and complement the direct sales approach. In support of our sales activities, we participate in industry trade shows, publish our own newsletters, place advertisements in other industry publications, publish articles in industrial and scientific publications, conduct direct mail campaigns, sponsor industry conferences and seminars, and maintain a World Wide Web site that contains information about us and our product and service offerings. Our customers' buying habits have historically resulted in a higher concentration of sales in the third quarter of our fiscal year. 11 This excerpt taken from the ACCL 10-Q filed Feb 9, 2005. Sales and marketing expenses decreased by 1% to $25.3 million in the nine months ended
December 31, 2004 compared to $25.6 million in the nine months ended December
31, 2003. Lower sales and marketing expenses were partially offset by the
expenses related to our New Business Development Group which was established
during calendar 2004.
| EXCERPTS ON THIS PAGE:
|
| |||||||